Not Yet Recruiting
MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07677475
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital) Dongguan, Guangdong, China